Analysts: Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

117.43USD
4:05pm EDT
Price Change (% chg)

$-3.09 (-2.56%)
Prev Close
$120.52
Open
$120.52
Day's High
$120.98
Day's Low
$116.64
Volume
420,480
Avg. Vol
321,307
52-wk High
$152.92
52-wk Low
$102.32

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.97 December 19 Sep 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 9 9 9 9
(2) OUTPERFORM 6 5 6 7
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 1 1 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.72 1.71 1.50 1.53

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 15 2,045.71 2,100.00 1,992.10 2,152.03
Quarter Ending Dec-14 15 2,213.29 2,309.00 2,152.30 2,273.90
Year Ending Dec-14 19 8,181.03 8,300.20 8,071.70 8,348.43
Year Ending Dec-15 19 8,869.30 9,414.00 8,550.78 8,817.77
Earnings (per share)
Quarter Ending Sep-14 16 1.97 2.03 1.90 2.26
Quarter Ending Dec-14 16 2.36 2.50 2.25 2.44
Year Ending Dec-14 19 8.00 8.20 7.90 8.65
Year Ending Dec-15 19 9.54 10.23 9.05 10.11
LT Growth Rate (%) 1 17.64 17.64 17.64 17.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 2,042.62 2,041.10 1.52 0.07
Quarter Ending Mar-14 1,968.73 1,886.20 82.53 4.19
Quarter Ending Dec-13 2,058.94 2,063.76 4.82 0.23
Quarter Ending Sep-13 1,671.61 1,541.73 129.88 7.77
Quarter Ending Jun-13 1,114.31 1,095.76 18.55 1.66
Earnings (per share)
Quarter Ending Jun-14 1.90 1.91 0.01 0.49
Quarter Ending Mar-14 1.72 1.76 0.04 2.12
Quarter Ending Dec-13 2.06 2.15 0.09 4.40
Quarter Ending Sep-13 1.41 1.43 0.02 1.17
Quarter Ending Jun-13 1.28 1.34 0.06 4.64

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 2,045.71 2,045.71 2,043.68 2,148.45 2,152.03
Quarter Ending Dec-14 2,213.29 2,213.29 2,212.09 2,303.32 2,273.90
Year Ending Dec-14 8,181.03 8,181.03 8,180.13 8,399.22 8,348.43
Year Ending Dec-15 8,869.30 8,869.30 8,885.44 9,028.41 8,817.77
Earnings (per share)
Quarter Ending Sep-14 1.97 1.97 1.96 2.35 2.26
Quarter Ending Dec-14 2.36 2.36 2.36 2.70 2.44
Year Ending Dec-14 8.00 8.00 7.99 8.71 8.65
Year Ending Dec-15 9.54 9.54 9.58 10.50 10.11

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 1 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 1 0
Year Ending Dec-15 0 0 2 0
Earnings
Quarter Ending Sep-14 0 0 1 0
Quarter Ending Dec-14 0 0 1 0
Year Ending Dec-14 0 0 1 0
Year Ending Dec-15 0 0 1 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Jefferson Research
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks